These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1637660)

  • 21. 5-fluorouracil induced cardiotoxicity in albino rats.
    Kumar S; Gupta RK; Samal N
    Mater Med Pol; 1995; 27(2):63-6. PubMed ID: 8935192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic cardiotoxicity associated with 5-fluorouracil.
    Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
    Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives.
    Lamberti M; Porto S; Zappavigna S; Addeo E; Marra M; Miraglia N; Sannolo N; Vanacore D; Stiuso P; Caraglia M
    Toxicol Lett; 2014 Jun; 227(3):151-6. PubMed ID: 24704391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.
    Köhne CH; Thuss-Patience P; Friedrich M; Daniel PT; Kretzschmar A; Benter T; Bauer B; Dietz R; Dörken B
    Br J Cancer; 1998 Mar; 77(6):973-7. PubMed ID: 9528843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW; Garcon MC; Rodriguez G; Rodriguez T
    In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes.
    Kivilcim M; Kazi AA; Peyman GA; Hegazy H; El Dessouky el-S; Cheema R; Laghari NA
    J Coll Physicians Surg Pak; 2006 May; 16(5):351-4. PubMed ID: 16756781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
    Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
    Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine.
    Okeda R; Shibutani M; Matsuo T; Kuroiwa T; Shimokawa R; Tajima T
    Acta Neuropathol; 1990; 81(1):66-73. PubMed ID: 2128162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of citrate metabolism by sodium fluoroacetate in the perfused rat heart and the effect on phosphofructokinase activity and glucose utilization.
    Bowman RH
    Biochem J; 1964 Nov; 93(2):13C-15C. PubMed ID: 4220932
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients.
    Labianca R; Beretta G; Clerici M; Fraschini P; Luporini G
    Tumori; 1982 Dec; 68(6):505-10. PubMed ID: 7168016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Dynamics in Rat Heart Induced by 5-Fluorouracil.
    Zhang D; Ma J
    Med Sci Monit; 2018 Sep; 24():6666-6672. PubMed ID: 30240386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of microbial contamination with multiple use of 5-fluorouracil vials.
    Mora JS; Cevallos V; Whitcher JP
    J Glaucoma; 1996 Dec; 5(6):371-4. PubMed ID: 8946292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorinated natural products: the biosynthesis of fluoroacetate and 4-fluorothreonine in Streptomyces cattleya.
    Murphy CD; Schaffrath C; O'Hagan D
    Chemosphere; 2003 Jul; 52(2):455-61. PubMed ID: 12738270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.
    Kato T; Shimamoto Y; Uchida J; Ohshimo H; Abe M; Shirasaka T; Fukushima M
    Anticancer Res; 2001; 21(3B):1705-12. PubMed ID: 11497250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity.
    Zhao D; Zhang H; Tao W; Wei W; Sun J; He Z
    Biomater Sci; 2017 Feb; 5(3):502-510. PubMed ID: 28116362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.
    Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M
    Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.